Figure 2.
Low-level and high-level minimal residual disease. Asynchronous coexpression of CD34 and CD15 at diagnosis (A); low-level MRD at follow-up (B). Overexpression of CD34 and CD13 at diagnosis (C); high-level MRD at follow-up (D).
Low-level and high-level minimal residual disease. Asynchronous coexpression of CD34 and CD15 at diagnosis (A); low-level MRD at follow-up (B). Overexpression of CD34 and CD13 at diagnosis (C); high-level MRD at follow-up (D).
